132 related articles for article (PubMed ID: 9430176)
21. Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline.
Elit L; Zitzelsberger L; Fung-Kee-Fung M; Brouwers M; Graham ID; Browman G; Hoskins P; Lau S; Ghatage P;
Gynecol Oncol; 2007 Jul; 106(1):181-92. PubMed ID: 17498781
[TBL] [Abstract][Full Text] [Related]
22. Clinical decision support systems: perspectives in dentistry.
Mendonça EA
J Dent Educ; 2004 Jun; 68(6):589-97. PubMed ID: 15217078
[TBL] [Abstract][Full Text] [Related]
23. Evaluating the quality of clinical guidelines. Linking decisions to medical evidence.
Djulbegovic B; Hadley T
Oncology (Williston Park); 1998 Nov; 12(11A):310-4. PubMed ID: 10028514
[TBL] [Abstract][Full Text] [Related]
24. Implementation of national comprehensive cancer network evidence-based guidelines to prevent and treat cancer-related infections.
Wood SK; Payne JK
Clin J Oncol Nurs; 2012 Jun; 16(3):E111-7. PubMed ID: 22641329
[TBL] [Abstract][Full Text] [Related]
25. Optimizing the Clinical Utility of Biomarkers in Oncology: The NCCN Biomarkers Compendium.
Birkeland ML; McClure JS
Arch Pathol Lab Med; 2015 May; 139(5):608-11. PubMed ID: 25333835
[TBL] [Abstract][Full Text] [Related]
26. Evidence-based guidelines and critical pathways for quality improvement.
Bergman DA
Pediatrics; 1999 Jan; 103(1 Suppl E):225-32. PubMed ID: 9917466
[TBL] [Abstract][Full Text] [Related]
27. Implications of lack of concordance among oncologists for evidence-based medicine derived clinical guidelines.
Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):228-30. PubMed ID: 14582215
[No Abstract] [Full Text] [Related]
28. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
29. [The German Guideline Clearinghouse on Breast Cancer: the need for frequent updating of breast cancer guidelines requires effective guideline updating procedures].
Weingart O; Sonntag D; Trapp H; Bartsch HH; Baumeister RG; Goerke K; Giersiepen K; Hindenburg HJ; Ming K; Schulz-Wendtland R; Störkel S; Kober T; Thole H; Kirchner H; Ollenschläger G;
Z Arztl Fortbild Qualitatssich; 2004 Aug; 98(5):403-11. PubMed ID: 15487388
[TBL] [Abstract][Full Text] [Related]
30. Guidelines on the use of intravenous immune globulin for hematologic conditions.
Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
[TBL] [Abstract][Full Text] [Related]
31. Guidelines on the use of intravenous immune globulin for neurologic conditions.
Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
[TBL] [Abstract][Full Text] [Related]
32. Using tumor registry resources in analyzing concordance with guidelines and outcomes.
Bookman MA
Oncology (Williston Park); 2000 Nov; 14(11A):104-7. PubMed ID: 11195403
[TBL] [Abstract][Full Text] [Related]
33. The electronic medical record: decision support and the effective use of clinical guidelines.
Jacob J
Alaska Med; 2003; 45(2):41-6. PubMed ID: 12971064
[TBL] [Abstract][Full Text] [Related]
34. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines.
Djulbegovic B
Best Pract Res Clin Haematol; 2005; 18(3):455-66. PubMed ID: 15792920
[TBL] [Abstract][Full Text] [Related]
35. An evidence-based approach to clinical practice guidelines in periodontics.
Bray KK; Williams K
Curr Opin Periodontol; 1997; 4():96-103. PubMed ID: 9655028
[TBL] [Abstract][Full Text] [Related]
36. Clinical practice guidelines in dentistry: Part I. Navigating new waters.
Sutherland SE; Matthews DC; Fendrich P
J Can Dent Assoc; 2001; 67(7):379-83. PubMed ID: 11468094
[TBL] [Abstract][Full Text] [Related]
37. A breast center review of compliance with National Comprehensive Cancer Network Breast Cancer guidelines.
Landercasper J; Dietrich LL; Johnson JM
Am J Surg; 2006 Oct; 192(4):525-7. PubMed ID: 16978966
[TBL] [Abstract][Full Text] [Related]
38. [Development of the evidence-based guidelines for psoriasis--a project of the German Dermatological Society (DDG)].
Follmann M; Sterry W; Rzany B; ;
J Dtsch Dermatol Ges; 2005 Sep; 3(9):678-89. PubMed ID: 16173975
[TBL] [Abstract][Full Text] [Related]
39. Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer.
Walsh GL; Winn RJ
Oncology (Williston Park); 1997 Nov; 11(11A):161-70. PubMed ID: 9430187
[TBL] [Abstract][Full Text] [Related]
40. Approaches for creating computer-interpretable guidelines that facilitate decision support.
de Clercq PA; Blom JA; Korsten HH; Hasman A
Artif Intell Med; 2004 May; 31(1):1-27. PubMed ID: 15182844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
